Psychiatry and Neurology, Neurology · Philadelphia, PA
NPI
1427367499
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
3509 N Broad St
Philadelphia, PA, 19140
Phone (215) 707-3040
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
311 services
Medicare patients, 2024
166
Average age 65
Drug cost, 2024
$4.0M
2,449 prescriptions
Company payments, 2025
$7,347
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Edward J Gettings Jr. was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 76 times for 55 patients. In total Edward J Gettings Jr. billed 311 services in 17 codes, and Medicare paid $18K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-08-12.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 76 | 55 | $11.91 | $905 |
| 99222 Hospital E&M - Initial | Facility | 62 | 62 | $102.57 | $6,359 |
| 99213 Office E&M - Established | Facility | 43 | 36 | $43.73 | $1,880 |
| 99214 Office E&M - Established | Facility | 25 | 22 | $63.06 | $1,576 |
| 99215 Office E&M - Established | Facility | 18 | 17 | $87.55 | $1,576 |
| 99232 Hospital E&M - Subsequent | Facility | 17 | 11 | $63.79 | $1,084 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 13 | 12 | $12.31 | $160 |
| 99213 Office E&M - Established | Office | 11 | 11 | $67.94 | $747 |
By year: 2022 $18K for 259 services; 2023 $21K for 269 services; 2024 $18K for 311 services.
Medicare prescription drug claims, 2024
In 2024, the drug Edward J Gettings Jr. prescribed most often to Medicare patients was Dalfampridine Er (Dalfampridine), with 276 prescriptions and refills. In total Edward J Gettings Jr. wrote 2,449 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dalfampridine Er Dalfampridine | 276 | 276 | 36 | $132K |
| Baclofen Generic | 143 | 183 | 26 | $2,211 |
| Gabapentin Generic | 133 | 163 | 26 | $1,754 |
| Topiramate Generic | 125 | 159 | 21 | $1,093 |
| Emgality Pen Galcanezumab-Gnlm | 113 | 124 | 15 | $87K |
| Tizanidine Hcl Generic | 93 | 109 | 19 | $2,952 |
| Zeposia Ozanimod Hydrochloride | 89 | 89 | Under 11 | $761K |
| Duloxetine Hcl Generic | 67 | 86 | 13 | $738 |
| Nurtec Odt Rimegepant Sulfate | 54 | 56 | Under 11 | $88K |
| Levetiracetam Generic | 53 | 71 | 11 | $1,006 |
| Donepezil Hcl Generic | 52 | 56 | Under 11 | $272 |
| Pregabalin Generic | 51 | 53 | 11 | $350 |
| Copaxone Glatiramer Acetate | 50 | 50 | Under 11 | $282K |
| Kesimpta Pen Ofatumumab | 49 | 53 | Under 11 | $466K |
| Dimethyl Fumarate Generic | 46 | 46 | Under 11 | $153K |
Brand drugs: - claims; generic drugs: 1,890 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Edward J Gettings Jr. $7,347 ($7,347 in general payments such as food, travel and fees) from 5 companies. The largest payer was Genentech USA, Inc. with $7,166.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.